Epidemiology and clinical course of brain arteriovenous malformations (BAVM)
BAVMs are a rare but treatable cause of stroke from bleeding
into the brain. These studies seek to define what the risks
of neurologic damage are from both the natural history of the
disease as well as from treatment of the disease. By knowing
the balance between natural history and treatment risks in different
subgroups of patients, more rational care can be offered to
patients. Use of novel clinical trial methodologies and statistical
modeling are used for this work. Parts of these studies are
undertaken in conjunction with Kaiser-Permanente Northern California
to examine aspects of natural history in a population-based
cohort.
|
|
|
Adaptation of the cerebral circulation to chronic arterial hypotension
BAVMs induce low blood pressure in surrounding normal areas
of brain. These clinical research studies examine the mechanisms
by which normal brain can adapt to chronic decreased perfusion
pressure. Preliminary evidence suggests involvement of some
change in endothelial or neuronal nitric-oxide signalling. This
work has been expanded to examine other clinical states which
may share aspects of the same pathophysiology, such as cerebral
hyperperfusion after percutaneous transluminal angioplasty and
stenting of the arterial supply to the brain.
|
|
|
Endothelial biology of brain cerebrovascular malformations
By examining surgical specimens with the tools of molecular
biology, the pathways associated with the development of human
vascular malformations can be studied. Examples of these malformations
include BAVMs, cavernous malformations, dural arteriovenous
fistulas, and aneurysms. By use of cell culture systems and
the development of small animal models, mechanistic studies
can be undertaken to unravel the missteps in development or
maturation which result in the human disease. From these studies,
insights into better treatment strategies can be undertaken.
A key system of interest is the Tie-2 / Angiopoietin signaling
pathway.
|
|
|
Manipulation of brain angiogenesis
By manipulating the relative levels of various angiogenic factors, either by gene delivery, protein infusion or transgenic mouse backgrounds, we are studying ways to simulate vascular malformations of the brain and devise innovative strategies for the treatment of cerebral ischemia. The figures show focal hyperstimulation of angiogenesis using adenoviral vectors to deliver VEGF to brain. On the left, stereotactic delivery of Ad-lacZ to the basal ganglia results in lacZ staining; on the right, lectin staining showing proliferation of the capillary bed with the characteristic appearance of neo-angiogenesis.
|
|
|
Computational modeling of the cerebral circulation
By the development of computational models, it is often possible
to take incomplete sets of experimental data and generate likely
hypotheses to further test. Further, theoretical modeling of
BAVM rupture risk can be used to improve selection of variables
to develop for use in risk stratification purposes in clinical
trials. A long-term goal of this line of inquiry is to eventually
develop "patient-specific" physiologic models that can be used
in conjunction with modern anatomic imaging for treatment planning
and outcome assessment.
In collaboration with scientists from The Vascular Imaging Research Center, we are studying the effect of abnormal flow profiles that are present in cerebral aneurysms and arteriovenous malformations using magnetic resonance imaging and computational fluid dynamic modeling.
|
|
|
Genetics of cerebrovascular anomalies
The genetic defects in several familial or inherited types of
stroke syndromes are known; much less well understood are the
genetic defects in "sporadic" stroke syndromes. In collaboration
with the UCSF Cardiovascular Research Institute
and the Department
of Genetics at Duke University, these studies are designed
to define the interaction of subtle genetic alterations in key
signaling pathways that are necessary for normal development
and maintenance of the vascular endothelium. If these systems
are not operating correctly, defects such as structural flaws
in the blood vessel or a predisposition to clot formation may
result.
|
|